TrialEuropean journal of clinical pharmacology2003

Consistent pharmacokinetics of the oral direct thrombin inhibitor ximelagatran in patients with nonvalvular atrial fibrillation and in healthy subjects.

Michael Wolzt et al.PubMed ↗Publisher ↗

No numbers read from the abstract.